Country

Clinical trials in Norway

Active obesity and GLP-1 studies with at least one location in Norway.

45active studies

28recruiting now

14countries represented

54largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Lamotrigine

Obesity, MorbidCondition

LamotrigineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-08-13 · NCT03497143See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Losartan

Obesity, MorbidCondition

LosartanTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-08-13 · NCT03519893See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Metoprolol

Obesity, MorbidCondition

MetoprololTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-08-13 · NCT03519906See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Valsartan

Obesity, MorbidCondition

ValsartanTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-08-13 · NCT03535376See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Paracetamol

Obesity, MorbidCondition

ParacetamolTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-08-13 · NCT03538457See eligibility →

Recruiting nowNot applicable

Effect of Patient Education on Drinking Behaviour and Oral Hygiene in Patients Undergoing Bariatric Surgery

Obesity, Bariatric Surgery CandidateCondition

Various levels of patient educationTreatment

Norway1 locations

St. Olavs HospitalSponsor

Updated 2026-07-20 · NCT06617689See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Ramipril

Obesity, MorbidCondition

RamiprilTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03440177See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Apixaban

Obesity, MorbidCondition

ApixabanTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03448783See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Quetiapine

Obesity, MorbidCondition

QuetiapineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03449472See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Chlorprothixene

Obesity, MorbidCondition

ChlorprothixeneTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03449485See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Candesartan

Obesity, MorbidCondition

CandesartanTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03460327See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Enalapril

Obesity, MorbidCondition

EnalaprilTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03460366See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Fluoxetine

Obesity, MorbidCondition

FluoxetineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03476525See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Gabapentin

Obesity, MorbidCondition

GabapentinTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03476538See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide

Obesity, MorbidCondition

HydrochlorothiazideTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03476551See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Ibuprofen

Obesity, MorbidCondition

IbuprofenTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03476577See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Irbesartan

Obesity, MorbidCondition

IrbesartanTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03476603See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Lercanidipine

Obesity, MorbidCondition

LercanidipineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-07-08 · NCT03497156See eligibility →

Recruiting nowNot applicable

Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity

Obesity, MorbidCondition

Single anastomosis sleeve ileal bypass, Sleeve gastrectomyTreatment

Norway2 locations

Oslo University HospitalSponsor

Updated 2026-05-18 · NCT05611697See eligibility →

Recruiting nowNot applicable

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Colorectal Cancer, Early Onset Colorectal CancerCondition

Semi Quantitative Food Frequency Questionnaire (SQFFQ)Treatment

Finland, Germany8 locations

San Raffaele UniversitySponsor

Updated 2026-04-24 · NCT05732623See eligibility →

Recruiting nowNot applicable

A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment

Childhood Obesity, Adolescent ObesityCondition

Evira Care treatment, Standard Lifestyle CareTreatment

Italy, Norway5 locations

Karolinska InstitutetSponsor

Updated 2025-10-06 · NCT04917601See eligibility →

Recruiting nowNot applicable

Norwegian Mental Illness Heart Health Study

Cardio Vascular Disease, Metabolic Syndrome (MetS)Condition

Lifestyle InterventionTreatment

Norway1 locations

Madeleine Elisabeth AngelsenSponsor

Updated 2025-10-02 · NCT07085923See eligibility →

Recruiting nowNot applicable

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Binge Eating Disorder Associated With Obesity, Binge Eating DisorderCondition

GLP-1, CBTe Group TherapyTreatment

Norway1 locations

Haukeland University HospitalSponsor

Updated 2025-09-15 · NCT07042672See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Venlafaxine

Obesity, MorbidCondition

VenlafaxineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2025-06-10 · NCT03532477See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Amlodipine

Obesity, MorbidCondition

AmlodipineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2025-06-06 · NCT02904291See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Buprenorphine

Obesity, MorbidCondition

BuprenorphineTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2023-03-27 · NCT03460314See eligibility →

Recruiting nowNot applicable

Bariatric Surgery and Pharmacokinetics of Escitalopram

Obesity, MorbidCondition

EscitalopramTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2023-03-27 · NCT03460379See eligibility →

Recruiting nowNot applicable

Dietary Strategies for Remission of Type 2 Diabetes

Diabetes Mellitus, Type 2, Overweight and ObesityCondition

Energy restricted diet, Low carbohydrate high fat dietTreatment

Norway1 locations

University of BergenSponsor

Updated 2022-07-08 · NCT04943926See eligibility →

Invitation onlyNot applicable

How Does Bariatric Surgery Affect Social Experiences and Well-being - The BaSES-study

ObesityCondition

Gastric bypass, Sleeve gastrectomyTreatment

Norway1 locations

The Hospital of VestfoldSponsor

Updated 2025-11-21 · NCT05207917See eligibility →

Active, not recruitingNot applicable

Time-restricted Eating and High-intensity Interval Training for Metabolic Health in Adults With Overweight/Obesity

Overweight and ObesityCondition

Time-restricted eating and high-intensity interval trainingTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-08-13 · NCT07036562See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Obesity, OverweightCondition

Cagrilintide, PlaceboTreatment

Argentina, Australia40 locations

Novo Nordisk A/SSponsor

Updated 2026-08-06 · NCT07220642See eligibility →

Active, not recruitingNot applicable

RE-inventing Strategies for Healthy Ageing; Recommendations and Tools

Lifestyle, Healthy, Muscle WeaknessCondition

Complex lifestyle intervention, Physical activity monitoring and recommendationsTreatment

Norway1 locations

University of TromsoSponsor

Updated 2026-04-29 · NCT06122441See eligibility →

Active, not recruitingNot applicable

4XL Study - Obesity Surgery in Adolescence

Obesity, MorbidCondition

Laparoscopic gastric bypass, Standard conservative treatmentTreatment

Norway1 locations

Sykehuset i Vestfold HFSponsor

Updated 2026-04-24 · NCT00923819See eligibility →

Active, not recruitingNot applicable

Effect of Exercise Training on Breastmilk Composition

ObesityCondition

ExerciseTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-04-08 · NCT05488964See eligibility →

Active, not recruitingNot applicable

Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance

Obesity (Body Mass Index >30 kg/m2)Condition

High-protein diet and resistance training, Balanced control dietTreatment

Norway1 locations

Norwegian University of Science and TechnologySponsor

Updated 2026-01-30 · NCT07113561See eligibility →

Active, not recruitingPhase 2

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 2, Diabetic Peripheral NeuropathyCondition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Canada, Denmark54 locations

Novo Nordisk A/SSponsor

Updated 2025-12-05 · NCT06797869See eligibility →

Active, not recruitingNot applicable

Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults

High CholesterolCondition

Herring oil concentrate, ControlTreatment

Norway1 locations

University of BergenSponsor

Updated 2025-10-02 · NCT06364163See eligibility →

Active, not recruitingNot applicable

Lifestyle Change: The Impact on Body Composition, Resting Metabolic Rate, Food Intake and Health-related Quality of Life

Obesity and OverweightCondition

Intensive behavioral change with physical activity and diet. A single-group pre-post designTreatment

Norway1 locations

VID Specialized UniversitySponsor

Updated 2025-08-05 · NCT07103005See eligibility →

Active, not recruitingNot applicable

Prevention of Coronary Heart Disease in Morbidly Obese Patients

Morbid Obesity, HypertensionCondition

Bariatric Surgery, Conservative Treatment:Treatment

Norway1 locations

The Hospital of VestfoldSponsor

Updated 2025-06-11 · NCT00626964See eligibility →

Active, not recruitingNot applicable

Effectiveness of Gradual Versus Rapid Weight Loss

ObesityCondition

Rapid weight loss (RWL) program, Gradual weight loss (GWL) programTreatment

Norway1 locations

The Hospital of VestfoldSponsor

Updated 2025-06-11 · NCT03776552See eligibility →

Active, not recruitingNot applicable

Non-randomized Prospective Comparison Between SASI Bipartition and RYGB

Obesity, Morbid, Metabolic SyndromeCondition

SASI Bipartition, Gastric bypassTreatment

Norway1 locations

Aleris HospitalSponsor

Updated 2025-02-06 · NCT04469712See eligibility →

Active, not recruitingNot applicable

Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers

ObesityCondition

Gastric bypass, Very low calorie dietTreatment

Norway1 locations

The Hospital of VestfoldSponsor

Updated 2024-10-02 · NCT02386917See eligibility →

Active, not recruitingNot applicable

Bypass Equipoise Sleeve Trial (BEST)

Severe ObesityCondition

gastric bypass, Sleeve gastrectomyTreatment

Norway, Sweden21 locations

Göteborg UniversitySponsor

Updated 2024-02-09 · NCT02767505See eligibility →

Active, not recruitingNot applicable

Alpha and Omega of Lifestyle Therapy

ObesityCondition

Resistance exercise, Omega-3Treatment

Norway1 locations

Inland Norway University of Applied SciencesSponsor

Updated 2022-08-09 · NCT04279951See eligibility →

Active, not recruitingNot applicable

Preventing Atopic Dermatitis and ALLergies in Children

Atopic Dermatitis, Food Allergy in ChildrenCondition

Food intervention, Skin careTreatment

Norway1 locations

Oslo University HospitalSponsor

Updated 2019-08-29 · NCT02449850See eligibility →

Related countries

United States1,107 China326 Canada158 France110 Spain98 Germany95

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.